Efficacy & safety of trastuzumab deruxtecan in breast cancer: A systematic review & meta-analysis
European Journal of Surgical Oncology（2023）
摘要
Introduction: Trastuzumab deruxtecan (T-DXd) is a novel antibody-drug-conjugate (ADC), primarily used in the treatment of HER2-positive breast cancer. This study aimed to conduct a systematic review to evaluate the efficacy and safety of T-DXd in treating breast cancer, based on clinical trials.
更多查看译文
关键词
trastuzumab deruxtecan,breast cancer,systematic review,meta-analysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要